Research News at AE Research

TBI, Oracle to jointly launch cloud-based vaccine management system
  : Akshay Kedari

Tony Blair Institute (TBI) and Oracle have recently introduced cloud technology to Africa for effective management of public health programs in the region. As per credible sources, initially, Ghana, Sierra Leone and Rw...


Read More >>
CDC funds $1.5 Mn for co-robots; aims to reduce worker exposure
  : Nikita Chaurasia

Projects developed through this grant is expected to be used in developing collaborative robots for use in the manufacturing and healthcare industries. ...


Read More >>
inmagene-biopharmaceuticals-secures-21-million-in-series-b-funding
  : Akshay Kedari

Inmagene Biopharmaceuticals, a Chinese pharmaceutical company, has recently revealed that it has logged US$21 million from its Series B funding round which was led by Vertex Ventures China. Reportedly, the funding saw ...


Read More >>
Clarivate launches EndNote 20 to enhance research management solutions
  : Nikita Chaurasia

Clarivate plc, a global leader in providing trusted information and insights, has reportedly launched new and enhanced EndNote™ 20, a reference management solution through whi...


Read More >>
Mental health startup Psyomics raises £1.5 million to launch ‘Censeo’
  : Akshay Kedari

U.K. headquartered HealthTech startup- Psyomics Ltd. has reportedly announced that it has raised nearly £1.5 million (USD 1.95 million) through a recent funding round led by the current as well as new investors, ...


Read More >>
OneOncology launches OneR to accelerate clinical research programs
  : Nikita Chaurasia

In recent developments, Tennessee-based oncology medical service provider OneOncology Inc., has reportedly announced the establishment of a newly formed subsidiary named OneR (OneOncology Research Network). ...


Read More >>
Varian’s IDE win makes way for first ever FLASH therapy clinical trial
  : Nikita Chaurasia

U.S.-based radiotherapy technology company, Varian Medical Systems has made it to the headlines for reportedly receiving an IDE (Investigational Device Exemption) from the U.S. Food & Drug Administration. ...


Read More >>
EU Grants €4.3 Mn for an Innovative Solar Energy Technology Research
  : Nikita Chaurasia

For the past few years, a specifically designed molecule and an energy system with exclusive abilities for capturing and storing solar power have been developed by a researcher’s group from the Chalmers Universit...


Read More >>
Researchers bag $6Mn grant to study the link between Parkinson’s & aging
  : Akshay Kedari

A three-year grant worth $6 million, funded by the Michael J. Fox Foundation, was recently awarded to a collaborative research team from Michigan’s Van Andel Institute (VAI) and the University of Minnesota Medica...


Read More >>
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
  : Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal pre...


Read More >>
Generac, Baker partner to offer solar & storage installations in U.S.
  : Nikita Chaurasia

Generac Holdings Inc., a Wisconsin-based leading backup power generation developer, has reportedly entered a joint venture agreement with a solar electric solutions provider Baker Electric 澳门新葡平台游戏网站home Energy. Sources close to the matter stated that the t...


Read More >>
Education analytics platform HelioCampus acquires ABC Insights
  : Nikita Chaurasia

HelioCampus, a leading higher education analytics platform that offers universities and colleges the decision-support assistance they require to work more sustainably and strategically, has reportedly announced that it...


Read More >>
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
  : Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Cente...


Read More >>
Novartis reveals positive data from Phase III ORION trials of inclisiran
  : Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprot...


Read More >>
Novartis notifies about Phase III COMBI-I study to treat skin cancer
  : Nikita Chaurasia

Reportedly, Novartis made an announcement that the COMBI-I study in its third phase that does evaluation of investigational immunotherapy spartalizumab (PDR001), combined with the targeted therapies Mekinist (tram...


Read More >>
Merck to develop USD 1.3 billion research center in London by 2025
  : Nikita Chaurasia

America-based leading pharmaceutical company Merck & Co. Inc. (MSD) is reportedly moving ahead with its plans of building a research center in London. Sources close to the matter stated that the new facility, which...


Read More >>
New research exposes hidden vulnerability in novel Coronavirus
  : Nikita Chaurasia

The research led by Monica Olvera de la Cruz, Lawyer Taylor Professor of Materials Science and Engineering, and Baofu Qiao, a research assistant professor at the Northwestern University, have reportedly discovered a ne...


Read More >>
NeuroRx, Relief Therapeutics declare results of RLF-100 clinical trials
  : Nikita Chaurasia

U.S.-based pharmaceutical company NeuroRx Inc., along with Relief Therapeutics Holding AG, a Swiss drug development company, have reportedly declared that aviptadil (RLF-100) clinical trials have showcased quick recupe...


Read More >>
PCI Pharma extends global clinical supply-chain services in Europe
  : Akshay Kedari

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) i...


Read More >>
Boehringer Ingelheim acquires GST to expand stem cell capabilities
  : Nikita Chaurasia

Boehringer Ingelheim, a leader in pharmaceutical products, has recently made it to the headlines by acquiring Belgium-based veterinary biotech firm, Global Stem cell Technology (GST). ...


Read More >>
JW gains solid tumor technology license through recent acquisition
  : Nikita Chaurasia

JW Therapeutics, a biotechnology company headquartered in Shanghai, China, has reportedly acquired Syracuse Biopharma (Hong Kong) Ltd., inclusive of a licensing agreement for Eureka Therapeutics’ solid tumor tech...


Read More >>
University of California launches unified COVID-19 research data center
  : Akshay Kedari

The University of California Health has reportedly launched a secure and centralized database known as UC CORDS in a bid to accelerate COVID-19 research. Sources with the relevant i...


Read More >>
Abcam & Cancer Research UK join forces to accelerate cancer research
  : Akshay Kedari

Cancer Research UK, one of the world's biggest independent funder of cancer research, has recently joined forces with Abcam plc, a leading developer of life science tools and reagents, to commercialize an...


Read More >>
Iridium shakes hands with Relativity Space to launch six satellites
  : Nikita Chaurasia

In the recent turn of events, Relativity Space, has reportedly inked an agreement with Iridium, with an aim to launch six next-generation communication satellites of the company. As...


Read More >>
Binance China Blockchain Institute joins forces with Xinyuan Group
  : Nikita Chaurasia

In a recent turn of events, Binance China Blockchain Institute, has reportedly signed a partnership deed with Xinyuan Group (NYSE:XIN), a Chinese real estate company with an aim to bring blockchain technology to the re...


Read More >>
DelMar to acquire Adgero Biopharmaceuticals in all-equity transaction
  : Nikita Chaurasia

DelMar Pharmaceuticals, Inc., the American-based biopharmaceutical company focused on the development of novel cancer therapies, has reportedly inked agreement to acquire Adgero Biopharmaceuticals Holdings, Inc. in an ...


Read More >>
National Congress of China recommends government-led blockchain fund
  : Nikita Chaurasia

The parliament of China, National People’s Congress, has reportedly given a suggestion for a blockchain development fund, backed by the government to be able to build up a good governance system. The most powerfu...


Read More >>
Halifax to initiate COVID-19 vaccine trials with CanSino Biologics
  : Nikita Chaurasia

The Dalhousie University, also known as Halifax University, located in Canada, has reportedly announced that its team would be working in collaboration with Chinese manufacturer, CanSino Biologics, to conduct the first...


Read More >>
VMware announces official acquisition of Kubernetes startup Octarine
  : Akshay Kedari

  VMware has announced its intention to purchase Kubernetes security startup Octarine. The CEO of VMware, Patrick Morley expressed this as a step in the right direction for the company to become a major security provi...


Read More >>
Researchers to investigate the risk of airborne viruses in buildings
  : Nikita Chaurasia

As the world gradually paces back to normalcy after recuperating from the devastating effects of COVID-19, a research team from DOE’s Lawrence Berkeley National Laboratory (Berkeley Lab) embarked on the quest to ...


Read More >>
AbCellera receives $175.6 mn from Canada for coronavirus research
  : Akshay Kedari

Healthcare companies are racing against time to develop a vaccine for COVID-19 which has killed thousands of people across the world. Given the dire situation, healthcare companies are seeking financial support from go...


Read More >>
Cannabis sativa extracts demonstrate potential to in COVID-19 treatment
  : Akshay Kedari

The University of Lethbridge, with Swysh, a company focused on cannabinoid R&D and Pathway Rx, a research company focused on developing custom cannabis therapies, are partnering to unravel a specific Cannabis sativ...


Read More >>
Novartis buys Amblyotech to develop digital therapy for amblyopia
  : Akshay Kedari

Novartis has recently made an announcement confirming that it has concluded its acquisition of Amblyotech, which is a software startup based in the U.S. Novartis will collaborate with McGill University and Ubisoft to b...


Read More >>
ThermoGenesis reveals intellectual property acquisition by ImmuneCyte
  : Akshay Kedari

ThermoGenesis Holdings, Inc. has recently announced the acquisition of intellectual property by ImmuneCyte Life Sciences, its joint venture. The acquisition has been made by ThermoGenesis, a market leader and pioneer i...


Read More >>
ALX Oncology raises $105 million in Series C financing for CD47 trials
  : Akshay Kedari

ALX Oncology, a clinical-stage biotechnology company, has secured $105 million in a Series C funding round, led by Vivo Capital. The new investors, who participated in the funding round include Janus Henderso...


Read More >>
NTT Research unveils 8 partnerships on quantum physics, neural network
  : Akshay Kedari

NTT Research has entered into five-year agreements with universities and other agencies   The joint framework will help boost its effor...


Read More >>
NTT Research partners with TUM on technologies to advance patient care
  : Akshay Kedari

NTT Research, Inc., has recently unveiled that its Medical and Health Informatics (MEI) Lab has signed a joint research agreement with the Technical University of Munich to work on three-dimensionally implantable and t...


Read More >>
TrakCel & McKesson partner to help commercialize gene & cell therapy
  : Nikita Chaurasia

The combination of these two product suites is designed specifically for the growing number of developers that are nearing the commercial launch of gene and cell therapies. The integrated platform allows t...


Read More >>
AECOM reveals plans to launch its PFAS eliminating tech DE-FLUORO™
  : Akshay Kedari

DE-FLUORO™ will be on display at the company’s booth at the eighth International Contaminated Site Remediation Conference, CleanUp 2019. AECOM, a multin...


Read More >>
TOI & CareMore care model showcases better cancer care at lower cost
  : Nikita Chaurasia

The study registered CareMore patients that were newly diagnosed with hematologic and solid malignancies from November 2016 to September 2018.   ...


Read More >>
MIT research shows positive results of skin patch for cancer treatment
  : Nikita Chaurasia

The skin patch designed, demonstrated positive results in an experiment on mice and human skin samples. The MIT researchers designed the patch to f...


Read More >>
Israeli researchers unveil 3D printed heart created from patient cells
  : Akshay Kedari

Apparently, this is a first project where the research community has been successful in engineering and printing an entire heart, complete with blood vessels, ventricles, chambers, and cells. ...


Read More >>
TRHC’s new pharmacotherapy R&D institute to be based in Orlando
  : Akshay Kedari

The newly established research institute will look forward to forging partnerships with significant pharmaceutical and academic entities in the region. Tabula Rasa ...


Read More >>
//